Lippo China Resources Limited Reports HK$396.8 Million Revenue for First Half of 2025

Reuters
09/29
Lippo China Resources Limited Reports HK$396.8 Million Revenue for First Half of 2025

Lippo China Resources Limited reported its unaudited interim results for the six months ended 30 June 2025. The Group recorded total revenue from contracts with customers of HK$396.8 million, up from HK$352.4 million in the prior-year period. Revenue from food manufacturing increased to HK$202.9 million from HK$166.4 million, while restaurant operations generated HK$187.8 million, compared to HK$179.5 million a year earlier. Revenue from provision of management services was HK$6.1 million, versus HK$6.5 million in the same period last year. The Group posted a net loss attributable to equity holders of HK$80.3 million for the period, an improvement from a net loss of HK$137.3 million for the same period in 2024. Loss for the period, including non-controlling interests, was HK$84.2 million, compared to HK$150.9 million previously. By geography, revenue from Hong Kong amounted to HK$130.2 million, up from HK$120.0 million. Revenue from the Republic of Singapore rose to HK$220.9 million from HK$220.9 million, while revenue from Mainland China was HK$1.0 million, down from HK$1.0 million, and revenue from Malaysia reached HK$10.4 million, up from HK$10.4 million. No outlook or guidance was included in the interim report.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lippo China Resources Limited published the original content used to generate this news brief on September 29, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10